DURECT Corporation (DRRX)
NASDAQ: DRRX · Real-Time Price · USD
0.799
-0.011 (-1.36%)
Feb 21, 2025, 4:00 PM EST - Market closed
DURECT Employees
DURECT had 58 employees as of December 31, 2023. The number of employees decreased by 21 or -26.58% compared to the previous year.
Employees
58
Change (1Y)
-21
Growth (1Y)
-26.58%
Revenue / Employee
$148,172
Profits / Employee
-$294,293
Market Cap
24.80M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
DRRX News
- 18 days ago - DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - PRNewsWire
- 24 days ago - DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence - PRNewsWire
- 3 months ago - DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million - PRNewsWire
- 3 months ago - DURECT Corporation (DRRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update - PRNewsWire
- 3 months ago - DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update - PRNewsWire
- 4 months ago - DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024 - PRNewsWire
- 5 months ago - DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis - PRNewsWire